SCHEMBL3798098

SCHEMBL3798098

C=CCN=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2839857 0.70
SCHEMBL1360009 0.70
SCHEMBL22104 0.70
SCHEMBL2839859 0.70
Methane SCHEMBL27500613 0.69
Hydrogen Sulfide SCHEMBL6714329 0.67
SCHEMBL724493 0.65
SCHEMBL18713314 0.65
SCHEMBL724492 0.65
SCHEMBL658732 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2108406-A1 Anionic dyes and hair dye compositions containing them DyStar Textilfarben GmbH & Co. Deutschland KG (DE) 2009-10-14 EP claimed
EP-0062876-B1 2-OXO-1-(((SUBSTITUTED SULFONYL)AMINO)CARBONYL)AZETIDINES E.R. Squibb &amp; Sons, Inc. (US) 1986-09-24 EP claimed
CN-117903110-A HBV inhibitors and uses thereof 西安新通药物研究股份有限公司 2024-04-19 CN disclosed
CN-114901639-B HBV inhibitors and uses thereof 西安新通药物研究股份有限公司 2023-11-24 CN disclosed
US-20230201353-A1 SUSTAINED RELEASE DELIVERY SYSTEMS COMPRISING TRACELESS LINKERS NOVARTIS AG (CH) 2023-06-29 US disclosed
CN-114901639-A HBV inhibitor and application thereof 西安新通药物研究股份有限公司 2022-08-12 CN disclosed
EP-2970074-B1 HYDROFORMYLATION PROVESS USING A HETEREOCYCLIC AGENT AS CATALYTIC STABILIZING AGENT DOW TECHNOLOGY INVESTMENTS LLC (US) 2019-04-24 EP disclosed
US-20170092435-A1 PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, DYE SOLUTION, AND TERPYRIDINE COMPOUND OR ESTERIFIED PRODUCT THEREOF FUJIFILM CORPORATION (JP) 2017-03-30 US disclosed
US-20170092434-A1 PHOTOELECTRIC CONVERSION ELEMENT, DYE-SENSITIZED SOLAR CELL, METAL COMPLEX DYE, AND DYE SOLUTION FUJIFILM CORPORATION (JP) 2017-03-30 US disclosed
US-9573870-B2 Hetereocyclic agent as catalytic stabilizing agent in a hydroformylation process DOW TECHNOLOGY INVESTMENTS LLC (US) 2017-02-21 US disclosed
US-20160250211-A1 AURORA KINASE INHIBITORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-09-01 US disclosed
US-4522933-A Hydroformylation catalyst containing bisphosphine monooxide ligands UNION CARBIDE CORPORATION (US) 1985-06-11 US disclosed
EP-0072560-B1 PROCESS FOR PREPARING ORGANIC TERTIARY POLYPHOSPHINE MONOOXIDES UNION CARBIDE CORPORATION (US) 1985-01-16 EP disclosed
US-4491675-A RHODIUM CATALYZED REACTION UNION CARBIDE CORPORATION (US) 1985-01-01 US disclosed
EP-0073398-B1 HYDROFORMYLATION PROCESS USING A RHODIUM COMPLEX CATALYST WITH TRIARYLPHOSPHINE AND BIPHOSPHINE MONOXIDE LIGANDS UNION CARBIDE CORPORATION (US) 1984-12-19 EP disclosed
US-4429161-A QUATERNIZATION OF POLYPHOSPHINE, ALKALINE HYDROLYSIS UNION CARBIDE CORPORATION (US) 1984-01-31 US disclosed
US-4400548-A Hydroformylation process using bisphosphine monooxide ligands UNION CARBIDE CORPORATION (US) 1983-08-23 US disclosed
EP-0073961-A1 Hydroformylation process using a rhodium complex catalyst with biphosphine monoxide ligands UNION CARBIDE CORPORATION (US) 1983-03-16 EP disclosed
EP-0073398-A1 Hydroformylation process using a rhodium complex catalyst with triarylphosphine and biphosphine monoxide ligands UNION CARBIDE CORPORATION (US) 1983-03-09 EP disclosed
EP-0072560-A2 Process for preparing organic tertiary polyphosphine monooxides UNION CARBIDE CORPORATION (US) 1983-02-23 EP disclosed